
Poseida’s Phase 1 trial that used an investigational CAR T therapy for treating prostate cancer has been suspended due to …

Biopharma firm Spring Bank Pharmaceuticals has revealed it has taken the decision to terminate all further development of inarigivir soproxil …

French clinical-stage biopharma firm Cellectis has received an order from the FDA to halt its study of CAR T therapy …

